1 / 15

Correlation of HBsAg and HBV DNA Michael Chudy, Paul-Ehrlich-Institut SoGAT XVIII, Bethesda MD

PEI. Correlation of HBsAg and HBV DNA Michael Chudy, Paul-Ehrlich-Institut SoGAT XVIII, Bethesda MD 24-25 May 2005. HBsAg and HBV DNA. Most sensitive HBsAg assay detects 0.01 ng/ml (PEI HBsAg standard; ad) HBsAg cut-off correspond to HBV DNA 114 IU/ml (WHO DNA standard)

ankti
Download Presentation

Correlation of HBsAg and HBV DNA Michael Chudy, Paul-Ehrlich-Institut SoGAT XVIII, Bethesda MD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. PEI Correlation of HBsAg and HBV DNA Michael Chudy, Paul-Ehrlich-Institut SoGAT XVIII, Bethesda MD 24-25 May 2005

  2. HBsAg and HBV DNA • Most sensitive HBsAg assay detects0.01 ng/ml (PEI HBsAg standard; ad) • HBsAg cut-off correspond to HBV DNA • 114 IU/ml (WHO DNA standard) • 461 copies/ml (five SC panels; ZeptoMetrix) Good correlation to published data from Biswas et al.; Transfusion 43:788-798 (2003)

  3. Virus and HBsAg Particles

  4. HBsAg reactive polypeptides • Most sensitive ELISA detects 10 pg HBsAg/ml • Virion-HBsAg • One HBV particle: 20 ag HBsAg* • 10 pg HBsAg correspond to about 500,000 HBV particles • 500 particles/ml (HBsAg cutoff of SC panels) vs. 500,000 HBV particles/ml • Viral surface antigen reactive polypeptides • Virion envelope • Incomplete viral forms • Excessive incomplete viral forms are present (about 1:1,000) *Average numbers of molecules of LHBs, MHBs, and SHBs: 30, 30, and 350, respectively; Calculation correlate well with data presented by Prof. Gerlich (EPFA meeting 2002)

  5. Correlation of HBsAg and HBV DNA Is that true for all geno-/subtypes, stages … of HBV infection? Can HBV NAT replace the HBsAg testing in blood donors?

  6. HBsAg and HBV DNA • HBV DNA: reverse transcription from 3.35 kb pre-genomic mRNA • HBsAg forms translated from LHBs 2.4 kb mRNA MHBs/SHBs 2.1 kb mRNA • Level of regulation • Transcription • Post-transcription e.g. Transport of unspliced mRNAs from nucleus to cytoplasm • Cellular factors

  7. Ratio of total HBsAg to Virion-HBsAgat different HBV stages • Early period of HBV infection • Genotype A • Genotype G • Chronic HBV infection

  8. 1:490 1:200 1:1,100 1:730 1:2,200 Total HBsAg/Virion-HBsAg ratio in samples of SC panel PHM911 (BBI)# 21 d #data performed in 1995

  9. HBV genotype G • Only few infections are known (all co-infections with genotype A) • First report of HBV infection and transmission based exclusively on genotype G (2003 in Germany) • No escape variant (subtype adw2) • HBeg minus variant • Studies were performed in cooperation with the Institute of • Transfusion Medicine and Immunohematology, GRC, • JW Goethe University, Frankfurt (WK Roth and co-workers)

  10. HBV transmission exclusively by genotype G-virus

  11. Virion-HBsAg/total HBsAg ratio in genotype G Sample from R3 (2003-09-23) with about 9 Mio cps/ml (positive for HBsAg, negative for anti-HBc, HBeAg/anti-HBe) • Titration in Prism HBsAg test • Virus concentration at HBsAg cut-off:24,000 copies/ml • Ratio of virion-HBsAg to total HBsAg of 1:20 • vs. 1:1,000 and more in genotype A samples of early HBV infection • Significant decrease of excessive HBsAg in infection with genotype G

  12. HBsAg and HBV DNA in chronic HBV infection • Lack of correlation between HBsAg and HBV DNA in HBsAg/anti-HBc positive tested samples (Kuhns et al. 2004, Transfusion 44,1332-1339)

  13. HBsAg and HBV DNA in chronic HBV carriers • Investigation of 106 chronic carriers tested positive for HBsAg, anti-HBc, and anti-HBe • Only 84% (89/106) HBV NAT reactive with the Procleix Ultrio Assay (Gen-Probe) • s/co >20 5x • s/co 15-20 65x • s/co 10-15 9x • s/co 5-10 7x • s/co <5 3x • No correlation to s/co values of HBsAg test (Prism)

  14. 17 HBsAg positive/HBV DNA negative samples of chronic HBV carriers

  15. Summary: Correlation ofHBsAg and HBV DNA • Virion-HBsAg of one particle (20 ag) correspond to one copy of HBV DNA • Significant excess of HBsAg particles in the early period of HBV infection (genotype A) • Variable ratio of Virion-HBsAg to total HBsAg in the course of infection (genotype A) • Genotype G infection shows a significant decrease in synthesis of incomplete viral forms • Lack of correlation between HBsAg and HBV DNA in chronic infection • HBsAg carrier (integrative phase) can be non-reactive by HBV NAT • Results indicate caution in any consideration of dropping HBsAg screening

More Related